DEXCOM INC — Director's Dealing 2018

Mar 14, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2018-03-12

Reporting Person: MOY JEFFREY (SVP, Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-12	Common Stock	D	1929	$60.7306	Disposed	73905	Direct
2018-03-12	Common Stock	D	2402	$60.7306	Disposed	71503	Direct
2018-03-12	Common Stock	D	2992	$60.7306	Disposed	68511	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	70400	Indirect

Footnotes

F1: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted.

F2: Included in this number are 55,681 unvested restricted stock units, 30,093 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 14,588 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 11,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019.